Home

search

Subjectguide
Journals
Books / Serials / Multimedia
Services
Services

Login for Subscribers
Logout

Sitemap
Help
Contacts


Logo






Vol. 68, No. 1, 1999  

Free Abstract   Article (Fulltext)    Article (PDF 256 KB)     

Special Article

Raising Questions about Antidepressants
David O. Antonuccioa, William G. Dantona, Garland Y. DeNelskyb, RogerP. Greenbergc, James S. Gordond

aUniversity of Nevada School of Medicine and Reno VA Medical Center, Reno, Nev.,
bCleveland Clinic Foundation, Cleveland, Ohio,
cSUNY Health Sciences Center at Syracuse, N.Y., and
dCenter for Mind-Body Medicine, Washington, D.C., USA

Address of Corresponding Author

Psychother Psychosom 1999;68:3-14 (DOI: 10.1159/000012304)


 goto top of page Key Words

  • Antidepressant drugs
  • Depressive disorder
  • Cognitive-behavioral psychotherapy
  • Placebo effect
  • Randomized control trials
  • Long-term outcome

 goto top of page Abstract

Antidepressant medication has apparently become the most popular treatment for depression in the USA. Several beliefs about the efficacy of antidepressant medications prevail among mental health professionals and the public. This paper explores relevant research data and raises questions about these beliefs. Many of the common beliefs about these medications are not adequately supported by scientific data. The following issues are raised: (1) industry-funded research studies which result in negative findings sometimes do not get published; (2) placebo washout procedures may bias results in some studies; (3) there are serious questions about the integrity of the double-blind procedure; (4) the ‘true’ antidepressant drug effect in adults appears to be relatively small; (5) there is minimal evidence of antidepressant efficacy in children; (6) side effects are fairly common even with the newer antidepressants; (7) combining medications raises the risk for more serious complications; (8) all antidepressants can cause withdrawal symptoms; (9) genetic influences on unipolar depression appear to be weaker than environmental influences; (10) biochemical theories of depression are as yet unproven; (11) biological markers specific for depression have been elusive; (12) dosage and plasma levels of antidepressants have been minimally related to treatment outcome; (13) preliminary evidence suggests that patients who improve with cognitive-behavioral psychotherapy show similar biological changes as those who respond to medication, and (14) the evidence suggests that psychological interventions are at least as effective as pharmacotherapy in treating depression, even if severe, especially when patient-rated measures are used and long-term follow-up is considered.


 goto top of page Author Contacts

David O. Antonuccio, PhD
Department of Psychiatry and Behavioral Sciences
University of Nevada School of Medicine
401 West 2nd Street, Suite 216, Reno, NV 89503 (USA)
Tel. +1 (702) 328 1490, E-Mail oliver2@aol.com


 goto top of page Article Information

Number of Print Pages : 12
Number of Figures : 0, Number of Tables : 0, Number of References : 162

 
Journal Home
Journal Content
Guidelines
Editorial Board
Aims and Scope
Subscriptions
Download Citation



This journal is part of the 5th subject package of the Karger

Journal Archive Collection

Information on packages (PDF)
Free sample issues


For non-native English speakers and international authors who would like assistance with their writing before submission, we suggest American Journal Experts for their scientific editing service.





copyright  © 2010 S. Karger AG, Basel